VA Medicinal Cannabis Research Act of 2021
- Last Action
- 11/4/2021
Actions
- 2021-11-04Ordered to be Reported by the Yeas and Nays: 18 - 11.
- 2021-11-04Committee Consideration and Mark-up Session Held.
- 2021-11-04Subcommittee on Health Discharged.
- 2021-10-14Subcommittee Hearings Held.
- 2021-07-14Referred to the Subcommittee on Health.
- 2021-04-30Referred to the House Committee on Veterans' Affairs.
- 2021-04-30Sponsor introductory remarks on measure. (CR E470)
- 2021-04-30Introduced in House
- 2021-04-30Introduced in House
CRS Summary
As of 2021-04-30 (00)
VA Medicinal Cannabis Research Act of 2021
This bill requires the Department of Veterans Affairs (VA) to conduct clinical trials of the effects of medical-grade cannabis on the health outcomes of covered veterans diagnosed with chronic pain and those diagnosed with post-traumatic stress disorder. Covered veterans are those who are enrolled in the VA health care system.
The trials must include a control group and an experimental group that are of similar sizes and structures and represent the demographics of the veteran population.
Data collected in the trials must be preserved to facilitate further research.
Under the bill, participation in the clinical trials does not affect a covered veteran's eligibility or entitlement to other VA benefits.
Cosponsors (6)
- Peter Meijer (R-MI)
- Elaine Luria (D-VA)
- Andy Kim (D-NJ)
- Suzan DelBene (D-WA)
- W. Steube (R-FL)
- Chris Pappas (D-NH)
Subjects
- Alternative treatments
- Congressional oversight
- Drug trafficking and controlled substances
- Government studies and investigations
- Health information and medical records
- Medical research
- Mental health
- Neurological disorders
- Veterans' medical care
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.